Examining recombinant human TSH primed 131I therapy protocol in patients with metastatic differentiated thyroid carcinoma: comparison with the traditional thyroid hormone withdrawal protocol
No Thumbnail Available
Click here to download
Date
2014
Journal Title
Journal ISSN
Volume Title
Publisher
Abstract
Description
Keywords
Recombinant human thyroid stimulating hormone, Differentiated thyroid carcinoma, Metastasis, Radiation absorbed dose, Effective half-life, Quality of life
Source
European Journal of Nuclear Medicine & Molecular Imaging, 2014. Vol. 41 (9): pp. 1767-1780